K182075 is an FDA 510(k) clearance for the BeneVision N Series Patient Monitors (Including BeneVision N12, BeneVision N15, BeneVision N17, BeneVision N19. BeneVision N22, BeneVision N1). This device is classified as a Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (Class II - Special Controls, product code MHX).
Submitted by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Shenzhen, TW). The FDA issued a Cleared decision on December 10, 2018, 131 days after receiving the submission on August 1, 2018.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1025.